Diseases affecting the anterior segment of the eye are the primary causes of vision
impairment and blindness globally. Drug administration through the topical ocular route is …

Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

Corticosteroids remain the mainstay of the treatment for various ocular conditions affecting
the ocular surface, anterior and posterior segments of the eye due to their anti-inflammatory …

Many therapies are available for the treatment of alopecia areata, including topical,
systemic, and injectable modalities. However, these treatment methods produce variable …

Glucocorticoids (GCs) represent the most important and frequently used class of anti-
inflammatory drugs. While the therapeutic effects of GCs have been known and used for …

Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

NHS Evidence has accredited the process used by the British Association of Dermatologists
to produce guidelines. Accreditation is valid for three years from May 2010 and is applicable …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

Cataract, opacification of the lens, is one of the commonest causes of loss of useful vision,
with an estimated 16 million people worldwide affected. Several risk factors have been …

Ocular allergy (OA), interchangeably known as allergic conjunctivitis, is a common
immunological hypersensitivity disorder affecting up to 40% of the population. Ocular allergy …